On the public citation graph

Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation

0 signed · 240 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/pd.4125openalex-snapshot
Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening
inferredcites →https://doi.org/10.1002/pd.4544openalex-snapshot
Women's uptake of non‐invasive DNA testing following a high‐risk screening test for trisomy 21 within a publicly funded healthcare system: findings from a retrospective review
inferredcites →https://doi.org/10.1002/pd.4637openalex-snapshot
Global perspectives on clinical adoption of NIPT
inferredcites →https://doi.org/10.1002/uog.13270openalex-snapshot
Potential diagnostic consequences of applying non‐invasive prenatal testing: population‐based study from a country with existing first‐trimester screening
inferredcites →https://doi.org/10.1002/uog.15820openalex-snapshot
Risk of fetal loss associated with invasive testing following combined first‐trimester screening for Down syndrome: a national cohort of 147 987 singleton pregnancies
inferredcites →https://doi.org/10.1002/uog.17484openalex-snapshot
Analysis of cell‐free DNA in maternal blood in screening for aneuploidies: updated meta‐analysis
inferredcites →https://doi.org/10.1002/uog.21945openalex-snapshot
Genome‐wide cfDNA testing of maternal blood
inferredcites →https://doi.org/10.1016/j.ajhg.2019.10.005openalex-snapshot
TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands
inferredcites →https://doi.org/10.1016/j.ajog.2014.06.038openalex-snapshot
Uptake of noninvasive prenatal testing at a large academic referral center
inferredcites →https://doi.org/10.1056/nejmoa1203382openalex-snapshot
Chromosomal Microarray versus Karyotyping for Prenatal Diagnosis
inferredcites →https://doi.org/10.1097/aog.0000000000001406openalex-snapshot
Practice Bulletin No. 163
inferredcites →https://doi.org/10.1111/aogs.13047openalex-snapshot
Analysis of cell‐free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population – a systematic review and meta‐analysis
inferredcites →https://doi.org/10.1159/000271995openalex-snapshot
Update on Procedure-Related Risks for Prenatal Diagnosis Techniques
inferredcites →https://doi.org/10.1186/s12913-017-2618-0openalex-snapshot
Implementing non-invasive prenatal testing for aneuploidy in a national healthcare system: global challenges and national solutions

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4416554openalex-extracted
Analyzing Challenges to Capabilities Approach in light of Scientific and Medical Developments
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.3689openalex-snapshot
Ultrasonographic Fetal Nuchal Translucency Measurements and Cytogenetic Outcomes
inferred← citeshttps://doi.org/10.1002/ajmg.c.32136openalex-snapshot
Non‐Invasive Prenatal Testing by Cell‐Free DNA ( cfNIPT ) for Detecting Turner Syndrome With Mosaicism and Structural Variants—Prenatal Findings and Postnatal Outcomes
inferred← citeshttps://doi.org/10.1002/ccr3.3211openalex-snapshot
Cell‐based noninvasive prenatal testing (cbNIPT) detects pathogenic copy number variations
inferred← citeshttps://doi.org/10.1002/ccr3.6280openalex-snapshot
Incidental finding of maternal malignancy in an unusual non‐invasive prenatal test and a review of similar cases
inferred← citeshttps://doi.org/10.1002/ijgo.15231openalex-snapshot
Early diagnosis of androgen insensitivity syndrome with cell‐free fetal DNA screening: A case report
inferred← citeshttps://doi.org/10.1002/jgc4.1402openalex-snapshot
How are uncertain prenatal genetic results perceived and managed two years after they were received? A qualitative interview study
inferred← citeshttps://doi.org/10.1002/jgc4.1635openalex-snapshot
Experiences of receiving an increased chance of sex chromosome aneuploidy result from non‐invasive prenatal testing in Australia: “A more complicated scenario than what I had ever realized”
inferred← citeshttps://doi.org/10.1002/jgc4.1769openalex-snapshot
Pregnant people's views and knowledge on prenatal screening for fetal trisomy in the absence of a national screening program
inferred← citeshttps://doi.org/10.1002/jgc4.1778openalex-snapshot
The emotional journey of adapting to prenatally identified trisomy X
inferred← citeshttps://doi.org/10.1002/jgc4.1951openalex-snapshot
Pregnant individuals' genetic literacy and decisional conflict about prenatal screening tests: A cross‐sectional study
inferred← citeshttps://doi.org/10.1002/jgc4.2025openalex-snapshot
Uptake rates for non‐invasive prenatal screening for single‐gene disorders associated with advanced paternal age
inferred← citeshttps://doi.org/10.1002/pd.5841openalex-snapshot
Discussing non‐invasive prenatal testing on Reddit: The benefits, the concerns, and the comradery
inferred← citeshttps://doi.org/10.1002/pd.5870openalex-snapshot
Right or wrong? Looking through the retrospectoscope to analyse predictions made a decade ago in prenatal diagnosis and fetal surgery
inferred← citeshttps://doi.org/10.1002/pd.6003openalex-snapshot
Does non‐invasive prenatal testing affect the livebirth prevalence of Down syndrome in the Netherlands? A population‐based register study
inferred← citeshttps://doi.org/10.1002/pd.6024openalex-snapshot
Increased nuchal translucency after low‐risk noninvasive prenatal testing: What should we tell prospective parents?
inferred← citeshttps://doi.org/10.1002/pd.6032openalex-snapshot
Non‐invasive prenatal testing 10 years on
inferred← citeshttps://doi.org/10.1002/pd.6043openalex-snapshot
Non‐invasive prenatal test uptake in socioeconomically disadvantaged neighborhoods
inferred← citeshttps://doi.org/10.1002/pd.6054openalex-snapshot
Increased nuchal translucency before 11 weeks of gestation: Reason for referral?
inferred← citeshttps://doi.org/10.1002/pd.6103openalex-snapshot
State‐wide increase in prenatal diagnosis of klinefelter syndrome on amniocentesis and chorionic villus sampling: Impact of non‐invasive prenatal testing for sex chromosome conditions
inferred← citeshttps://doi.org/10.1002/pd.6217openalex-snapshot
Ethical issues associated with prenatal screening using non‐invasive prenatal testing for sex chromosome aneuploidy
inferred← citeshttps://doi.org/10.1002/pd.6242openalex-snapshot
Factors involved in the decision to decline prenatal screening with noninvasive prenatal testing (NIPT)
inferred← citeshttps://doi.org/10.1002/pd.6243openalex-snapshot
How do women want to receive information about non‐invasive prenatal testing? Evidence from a discrete choice experiment
inferred← citeshttps://doi.org/10.1002/pd.6250openalex-snapshot
Klinefelter Syndrome: What should we tell prospective parents?
inferred← citeshttps://doi.org/10.1002/pd.6271openalex-snapshot
Positive predictive values and outcomes for uninformative cell‐free DNA tests: An Italian multicentric Cytogenetic and cytogenomic Audit of diagnOstic testing (ICARO study)
inferred← citeshttps://doi.org/10.1002/pd.6275openalex-snapshot
Isolation of single circulating trophoblasts from maternal circulation for noninvasive fetal copy number variant profiling
inferred← citeshttps://doi.org/10.1002/pd.6278openalex-snapshot
Issues associated with possible implementation of Non‐Invasive Prenatal Testing (NIPT) in first‐tier screening: A rapid scoping review
inferred← citeshttps://doi.org/10.1002/pd.6296openalex-snapshot
Non‐invasive prenatal testing for everybody or contingent screening?
inferred← citeshttps://doi.org/10.1002/pd.6322openalex-snapshot
Inclusion of sex chromosomes in noninvasive prenatal testing in Asia, Australia, Europe and the USA: A survey study
inferred← citeshttps://doi.org/10.1002/pd.6329openalex-snapshot
A cross‐country comparison of pregnant women's decision‐making and perspectives when opting for non‐invasive prenatal testing in the Netherlands and Belgium
inferred← citeshttps://doi.org/10.1002/pd.6357openalex-snapshot
Position statement from the International Society for Prenatal Diagnosis on the use of non‐invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnancies
inferred← citeshttps://doi.org/10.1002/pd.6387openalex-snapshot
How does cell‐based non‐invasive prenatal test (NIPT) perform against chorionic villus sampling and cell‐free NIPT in detecting trisomies and copy number variations? A clinical study from Denmark
inferred← citeshttps://doi.org/10.1002/pd.6388openalex-snapshot
Non‐invasive prenatal testing (NIPT) in twin pregnancies affected by early single fetal demise: A systematic review of NIPT and vanishing twins
inferred← citeshttps://doi.org/10.1002/pd.6389openalex-snapshot
Current practice of first‐trimester ultrasound screening for structural fetal anomalies in developed countries
inferred← citeshttps://doi.org/10.1002/pd.6393openalex-snapshot
First‐trimester screening strategies: A balance between costs, efficiency and diagnostic yield
inferred← citeshttps://doi.org/10.1002/pd.6423openalex-snapshot
What helps define outcomes in persistent uninterpretable non‐invasive prenatal testing: Maternal factors, fetal fraction or quality scores?
inferred← citeshttps://doi.org/10.1002/pd.6477openalex-snapshot
Current controversies in prenatal diagnosis: Noninvasive prenatal testing should replace other screening strategies for fetal trisomies 13, 18, 21
inferred← citeshttps://doi.org/10.1002/pd.6478openalex-snapshot
Cell‐free DNA methylation‐based preeclampsia prediction: A journey to improve maternal health
inferred← citeshttps://doi.org/10.1002/pd.6558openalex-snapshot
Use of cell‐free non‐invasive prenatal testing in pregnancies affected by placental mosaicism
inferred← citeshttps://doi.org/10.1002/pd.6696openalex-snapshot
‘I Could Trust It’: Experiences of Reciprocal Translocation Carriers and Their Partners With Prenatal Cell‐Free DNA Screening for Unbalanced Translocations
inferred← citeshttps://doi.org/10.1002/pd.6708openalex-snapshot
Comparing the Introduction and Implementation of Noninvasive Prenatal Testing (NIPT) in Japan, the Netherlands, and the United States: An Integrative Review
inferred← citeshttps://doi.org/10.1002/pd.6837openalex-snapshot
Chorionic Villus Sampling for Rapid Confirmation of High‐Risk NIPT Results for Trisomy 21, 18, and 13
inferred← citeshttps://doi.org/10.1002/pd.6842openalex-snapshot
Patient Preferences and Understanding of Genome‐Wide Cell‐Free DNA Screening for Foetal Chromosomal Imbalances: A Survey Study
inferred← citeshttps://doi.org/10.1002/pd.6888openalex-snapshot
Residual Risks of Fetal Chromosome Aberrations When Cell‐Free DNA Prenatal Screening Is Normal: A Retrospective Study
inferred← citeshttps://doi.org/10.1002/pd.6889openalex-snapshot
Perspectives on Fetal Sex and Prenatal Diagnosis of Differences of Sex Development Among Midwives
inferred← citeshttps://doi.org/10.1002/pd.70108openalex-snapshot
Prenatal Deep Phenotyping in Genetic Syndromes Diagnosed in the First Trimester of Pregnancy
inferred← citeshttps://doi.org/10.1002/pd.70191openalex-snapshot
Quality of Evidence for Prenatal Down Syndrome Screening: An Umbrella Review
inferred← citeshttps://doi.org/10.1002/pmf2.70139openalex-snapshot
Society for Maternal‐Fetal Medicine Consult Series #74: Cell‐free DNA screening for aneuploidies: Updated guidance
inferred← citeshttps://doi.org/10.1002/uog.27667openalex-snapshot
Combined first‐trimester screening and invasive diagnostics for atypical chromosomal aberrations: Danish nationwide study of prenatal profiles and detection compared with NIPT
inferred← citeshttps://doi.org/10.1007/978-3-031-26098-8_3openalex-snapshot
Causes of Congenital Malformations
inferred← citeshttps://doi.org/10.1007/978-3-031-31758-3_22openalex-snapshot
Maternal Secondary Genomic Findings Detected by Fetal Genetic Testing
inferred← citeshttps://doi.org/10.1007/978-3-031-31758-3_25openalex-snapshot
International Guidelines for Implementation of NIPT/cffDNA Testing
inferred← citeshttps://doi.org/10.1007/978-3-031-83545-2_14openalex-snapshot
Molecular Diagnosis of Gestational Trophoblastic Disease
inferred← citeshttps://doi.org/10.1007/978-3-662-44369-9_7-2openalex-snapshot
Anwendung genetischer Untersuchungen in der Pränataldiagnostik
inferred← citeshttps://doi.org/10.1007/978-3-662-63506-3_7openalex-snapshot
Anwendung genetischer Untersuchungen in der Pränataldiagnostik
inferred← citeshttps://doi.org/10.1007/978-3-662-70578-0_10openalex-snapshot
Genetic Analysis in Prenatal Diagnosis
inferred← citeshttps://doi.org/10.1007/978-90-368-2994-6_4openalex-snapshot
Reproductive medicine: ethical reflections
inferred← citeshttps://doi.org/10.1007/978-981-97-6402-0_1openalex-snapshot
Evolution of Noninvasive Prenatal Screening: Past to Present
inferred← citeshttps://doi.org/10.1007/978-981-97-6402-0_15openalex-snapshot
Implementation of Noninvasive Prenatal Screening (NIPS) in Clinical Practice: Comparison of Developed Versus Developing Countries
inferred← citeshttps://doi.org/10.1007/978-981-97-6402-0_3openalex-snapshot
Cell-Free Fetal DNA: Genesis and Clinical Utility
inferred← citeshttps://doi.org/10.1007/s00129-021-04834-0openalex-snapshot
Aneuploidiescreening: Welche Strategien sind möglich und sinnvoll?
inferred← citeshttps://doi.org/10.1007/s00129-024-05225-xopenalex-snapshot
NIPT in der Schwangerenvorsorge: Erkenntnisse und Erfahrungen nach Aufnahme in die Mutterschaftsrichtlinien
inferred← citeshttps://doi.org/10.1007/s00404-022-06908-3openalex-snapshot
Non-invasive prenatal test findings in 41,819 pregnant women: results from a clinical laboratory in southern China
inferred← citeshttps://doi.org/10.1007/s00404-025-08143-yopenalex-snapshot
Can cell-free fetal DNA screening be utilized for the assessment of chromosomal abnormalities in fetuses with mildly increased nuchal translucency?
inferred← citeshttps://doi.org/10.1007/s10728-024-00487-xopenalex-snapshot
Understanding the Normativity of Health Technology Assessment: Ontological, Moral, and Epistemological Commitments
inferred← citeshttps://doi.org/10.1007/s11019-023-10143-1openalex-snapshot
“Overestimated technology – underestimated consequences” – reflections on risks, ethical conflicts, and social disparities in the handling of non-invasive prenatal tests (NIPTs)
inferred← citeshttps://doi.org/10.1007/s12015-021-10228-5openalex-snapshot
Amniotic fluid stem cells and the cell source repertoire for non-invasive prenatal testing
inferred← citeshttps://doi.org/10.1007/s12687-024-00751-6openalex-snapshot
Healthcare professionals’ experiences with expanded noninvasive prenatal screening: challenges and solutions
inferred← citeshttps://doi.org/10.1007/s12687-026-00864-0openalex-snapshot
Genetic counselors’ perspectives on the expanded use of non-invasive prenatal testing
inferred← citeshttps://doi.org/10.1016/b978-0-12-823329-0.00007-6openalex-snapshot
A flow from screening to diagnostics
inferred← citeshttps://doi.org/10.1016/b978-0-323-91380-5.00013-7openalex-snapshot
Noninvasive prenatal testing/screening by circulating cell-free DNA
inferred← citeshttps://doi.org/10.1016/j.ajhg.2022.04.018openalex-snapshot
Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study
inferred← citeshttps://doi.org/10.1016/j.ajog.2021.03.050openalex-snapshot
Reexamining the optimal nuchal translucency cutoff for diagnostic testing in the cell-free DNA and microarray era: results from the Victorian Perinatal Record Linkage study
inferred← citeshttps://doi.org/10.1016/j.ajog.2024.08.017openalex-snapshot
The use of free DNA for fetal RHD genotyping in the Rh negative pregnant patient—the time has come
inferred← citeshttps://doi.org/10.1016/j.ajogmf.2022.100790openalex-snapshot
Clinical impacts of genome-wide noninvasive prenatal testing for rare autosomal trisomy
inferred← citeshttps://doi.org/10.1016/j.bpobgyn.2024.102543openalex-snapshot
Implementing non-invasive prenatal testing in a national screening program: Lessons learned from the TRIDENT studies
inferred← citeshttps://doi.org/10.1016/j.cll.2022.09.014openalex-snapshot
Applications of Noninvasive Prenatal Testing for Subchromosomal Copy Number Variations Using Cell-Free DNA
inferred← citeshttps://doi.org/10.1016/j.ebiom.2024.105039openalex-snapshot
Taking a step beyond serology: progress in the search for a biomarker predicting the risk of maternal-fetal transmission of cytomegalovirus (CMV)
inferred← citeshttps://doi.org/10.1016/j.ejogrb.2021.01.008openalex-snapshot
Non invasive prenatal testing (NIPT) for common aneuploidies and beyond
inferred← citeshttps://doi.org/10.1016/j.ejogrb.2023.06.009openalex-snapshot
Financial contribution as reason to opt out of non-invasive prenatal testing
inferred← citeshttps://doi.org/10.1016/j.ejogrb.2024.09.014openalex-snapshot
Non-invasive prenatal testing: Assessing the availability and accessibility of information available to the pregnant population within the Republic of Ireland
inferred← citeshttps://doi.org/10.1016/j.ejogrb.2026.115035openalex-snapshot
Screening for major aneuploidies at 10 weeks of gestation in an unselected population: comparing the combined test to the non-invasive prenatal testing with rolling-circle replication (SAPERER study)
inferred← citeshttps://doi.org/10.1016/j.eurox.2024.100327openalex-snapshot
The role of patient-reported experiences in disclosing genetic prenatal testing: Findings from a large-scale survey on pregnant women
inferred← citeshttps://doi.org/10.1016/j.gim.2025.101624openalex-snapshot
What do we mean by actionability? Examining a key criterion in genomic prenatal and newborn screening
inferred← citeshttps://doi.org/10.1016/j.gimo.2024.101821openalex-snapshot
Informal prenatal genetic screening education: What can you learn from Google and YouTube?
inferred← citeshttps://doi.org/10.1016/j.gine.2024.100985openalex-snapshot
Impacto del test prenatal no invasivo en la detección de aneuploidías
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e40379openalex-snapshot
A decade later: Assessing pregnant women's perspectives on non-invasive prenatal testing (NIPT) in Saudi Arabia
inferred← citeshttps://doi.org/10.1016/j.jogoh.2022.102329openalex-snapshot
Is Cell-Free Fetal DNA Testing a Safe Option for Women in a High-Risk Population after Combined First-Trimester Testing?
inferred← citeshttps://doi.org/10.1016/j.midw.2026.104827openalex-snapshot
Perspectives of women who receive an increased chance result on non-invasive prenatal testing or combined first trimester screening: a qualitative study
inferred← citeshttps://doi.org/10.1016/j.pec.2021.04.009openalex-snapshot
To what extent do decision aids for prenatal screening and diagnosis address involvement of partners in decision-making? - An environmental scan
inferred← citeshttps://doi.org/10.1016/j.pecinn.2022.100038openalex-snapshot
Do online decision aids reflect new prenatal screening and testing options? An environmental scan and content analysis
inferred← citeshttps://doi.org/10.1016/j.pecinn.2026.100462openalex-snapshot
Comprehensiveness, quality, and readability of non-invasive prenatal testing information on Japanese medical institution websites
inferred← citeshttps://doi.org/10.1016/j.placenta.2023.02.012openalex-snapshot
Diagnosis of hydatidiform moles using circulating gestational trophoblasts isolated from maternal blood
inferred← citeshttps://doi.org/10.1016/j.placenta.2024.04.012openalex-snapshot
The impact of confined placental mosaicism on prenatal cell-free DNA screening: Insights from a monocentric study of 99 cases
inferred← citeshttps://doi.org/10.1016/j.ssmqr.2023.100374openalex-snapshot
Finding out the “gender” sooner: Ethical tensions and parental motivation in discovering fetal sex and chromosomal anomaly risk using noninvasive prenatal testing (NIPT)
inferred← citeshttps://doi.org/10.1016/j.yamp.2021.07.002openalex-snapshot
Applications of Noninvasive Prenatal Testing for Subchromosomal Copy Number Variations Using Cell-Free DNA
inferred← citeshttps://doi.org/10.1038/s10038-022-01041-0openalex-snapshot
Chromosomal microarray analysis versus noninvasive prenatal testing in fetuses with increased nuchal translucency
inferred← citeshttps://doi.org/10.1038/s41431-020-00748-yopenalex-snapshot
Estimation of the number of people with Down syndrome in Europe
inferred← citeshttps://doi.org/10.1038/s41431-021-00940-8openalex-snapshot
Routinization of prenatal screening with the non-invasive prenatal test: pregnant women’s perspectives
inferred← citeshttps://doi.org/10.1038/s41431-022-01248-xopenalex-snapshot
Experiences of pregnant women with genome-wide non-invasive prenatal testing in a national screening program
inferred← citeshttps://doi.org/10.1038/s41436-021-01101-4openalex-snapshot
Outcome of publicly funded nationwide first-tier noninvasive prenatal screening
inferred← citeshttps://doi.org/10.1038/s44360-026-00104-2openalex-snapshot
Large-scale implementation of non-invasive prenatal testing for fetal aneuploidies
inferred← citeshttps://doi.org/10.1055/a-1534-2599openalex-snapshot
Integrating Combined First Trimester Screening for Preeclampsia into Routine Ultrasound Examination
inferred← citeshttps://doi.org/10.1055/a-2202-5282openalex-snapshot
First Trimester Contingent Screening for Aneuploidies with Cell-Free Fetal DNA in Singleton Pregnancies – a Swiss Single Centre Experience
inferred← citeshttps://doi.org/10.1080/01443615.2023.2204959openalex-snapshot
Evaluation of pre-test counselling offered for non-invasive prenatal testing (NIPT) as a primary screening tool
inferred← citeshttps://doi.org/10.1080/01443615.2023.2288226openalex-snapshot
Discordant performances of non-invasive prenatal testing for foetal trisomy 21 screening in subgroups of pregnancies
inferred← citeshttps://doi.org/10.1080/09505431.2023.2251998openalex-snapshot
Bioconstitutional visions in the debate on non-invasive prenatal testing in Germany
inferred← citeshttps://doi.org/10.1080/10408363.2022.2162843openalex-snapshot
Focus on the frontier issue: progress in noninvasive prenatal screening for fetal trisomy from clinical perspectives
inferred← citeshttps://doi.org/10.1080/14737159.2025.2453506openalex-snapshot
Gestational trophoblastic disease: STR genotyping for precision diagnosis
inferred← citeshttps://doi.org/10.1080/14767058.2023.2183742openalex-snapshot
Parental decision-making for prenatal screening tests in a Middle-Eastern population
inferred← citeshttps://doi.org/10.1080/15265161.2021.1996659openalex-snapshot
Non-Invasive Prenatal Testing for “Non-Medical” Traits: Ensuring Consistency in Ethical Decision-Making
inferred← citeshttps://doi.org/10.1080/15398285.2024.2374178openalex-snapshot
Decoding Promises and Perceptions: A Reflexive Thematic Analysis of the Online Presentation of Noninvasive Prenatal Testing (NIPT) in Top U.S. Brands
inferred← citeshttps://doi.org/10.1080/23294515.2026.2691708openalex-snapshot
“It’s an Uphill Battle. We Have a Long Way to Go”: Perspectives of Canadian Individuals Living with Genetic Conditions Detectable by Prenatal Cell-Free DNA Screening
inferred← citeshttps://doi.org/10.1086/732893openalex-snapshot
Targeting Precision Medicine: Evidence from Prenatal Screening
inferred← citeshttps://doi.org/10.1093/clinchem/hvab014openalex-snapshot
Variability of “Reported Fetal Fraction” in Noninvasive Prenatal Screening (NIPS)
inferred← citeshttps://doi.org/10.1093/humupd/dmab005openalex-snapshot
A systematic review and meta-analysis on the association between ICSI and chromosome abnormalities
inferred← citeshttps://doi.org/10.1093/oso/9780192870957.003.0001openalex-snapshot
Introduction
inferred← citeshttps://doi.org/10.1093/oso/9780192870957.003.0004openalex-snapshot
The Healthcare System
inferred← citeshttps://doi.org/10.1097/gco.0000000000000690openalex-snapshot
Is it time for prenatal chromosomal-microarray analysis to all women? A review of the diagnostic yield in structurally normal fetuses
inferred← citeshttps://doi.org/10.1097/grf.0000000000000802openalex-snapshot
Navigation of Prenatal Care With Sex Discordance Between Cell-free DNA and Ultrasound Findings
inferred← citeshttps://doi.org/10.1111/ajo.13533openalex-snapshot
Clinician views and experiences of non‐invasive prenatal genetic screening tests in Australia
inferred← citeshttps://doi.org/10.1111/ajo.13935openalex-snapshot
Public Perspectives Around Prenatal Screening of Chromosomal Abnormalities: A Focus Group Study Comparing Metropolitan and Rural/Regional Areas in Australia
inferred← citeshttps://doi.org/10.1111/aogs.13877openalex-snapshot
Nuchal translucency of 3.0‐3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review
inferred← citeshttps://doi.org/10.1111/aogs.13882openalex-snapshot
Personalized medicine for the embryo and the fetus – Options in modern genetics influence preconception and prenatal choices
inferred← citeshttps://doi.org/10.1111/aogs.14052openalex-snapshot
National data on the early clinical use of non‐invasive prenatal testing in public and private healthcare in Denmark 2013–2017
inferred← citeshttps://doi.org/10.1111/aogs.14091openalex-snapshot
Uptake of fetal aneuploidy screening after the introduction of the non‐invasive prenatal test: A national population‐based register study
inferred← citeshttps://doi.org/10.1111/aogs.14351openalex-snapshot
Controversies in implementing n on‐invasive prenatal testing in a public antenatal care program
inferred← citeshttps://doi.org/10.1111/aogs.14631openalex-snapshot
A decade of change – lessons learned from prenatal diagnostics in Central Denmark region in 2008–2018
inferred← citeshttps://doi.org/10.1111/cga.12586openalex-snapshot
Feelings and thoughts about life selection in pregnant women undergoing non‐invasive prenatal testing in Japan
inferred← citeshttps://doi.org/10.1111/cge.14399openalex-snapshot
Noninvasive prenatal diagnosis of Mendelian disorders for consanguineous couples by relative genotype dosage
inferred← citeshttps://doi.org/10.1111/jog.15513openalex-snapshot
Factors related to indecisive attitudes toward non‐invasive prenatal testing among women of reproductive age in Japan
inferred← citeshttps://doi.org/10.1111/jog.15740openalex-snapshot
Change in client choice under multiple prenatal genetic testing options including noninvasive prenatal testing (NIPT) after genetic counseling in a Japanese maternity hospital
inferred← citeshttps://doi.org/10.1111/jog.16052openalex-snapshot
Impact of the new government‐involved noninvasive prenatal testing certification system on the awareness of pregnant women about noninvasive prenatal testing in Japan
inferred← citeshttps://doi.org/10.1111/jog.16324openalex-snapshot
Changes in the attitudes of women who have undergone NIPT toward prenatal testing: The impact of the introduction of the prenatal testing certification system in Japan
inferred← citeshttps://doi.org/10.1111/tog.12988openalex-snapshot
Applications for cell‐free fetal DNA testing beyond common aneuploidy
inferred← citeshttps://doi.org/10.1136/bmjccgg-2026-000089openalex-snapshot
Population and test characteristics of non-invasive prenatal testing (NIPT) during the evaluative rollout in England as part of a national screening programme
inferred← citeshttps://doi.org/10.1136/bmjopen-2021-057658openalex-snapshot
Non-invasive prenatal testing in mitigating concerns from invasive prenatal diagnostic testing: retrospective assessment of utility in an academic healthcare system in the US
inferred← citeshttps://doi.org/10.1136/bmjph-2024-001074openalex-snapshot
Mainstreaming genetics into Italian prenatal care: exploring the future implementation of non-invasive prenatal testing (NIPT) in the Italian National Healthcare System using stakeholder interviews
inferred← citeshttps://doi.org/10.1146/annurev-biodatasci-020722-094144openalex-snapshot
Noninvasive Prenatal Testing Using Circulating DNA and RNA: Advances, Challenges, and Possibilities
inferred← citeshttps://doi.org/10.1146/annurev-genom-083118-015053openalex-snapshot
The Emergence and Global Spread of Noninvasive Prenatal Testing
inferred← citeshttps://doi.org/10.1159/000549331openalex-snapshot
Balancing How Much We Want to Know with What We Are Willing to Pay: A Comparative Cost Analysis of Prenatal Cytogenetic Testing and Screening Strategies
inferred← citeshttps://doi.org/10.11606/d.3.2022.tde-05092022-084236openalex-snapshot
Accelerating the alignment phase of Minimap2 genome assembly algorithm Using GACT-X in a commercial Cloud FPGA machine.
inferred← citeshttps://doi.org/10.1177/09691413211031610openalex-snapshot
Prenatal serum screening for Down syndrome and neural tube defects in the United States: Changes in utilization patterns from 2012 to 2020
inferred← citeshttps://doi.org/10.1177/13634593251377111openalex-snapshot
“Do you want to know or not?” How prenatal providers manage clinical uncertainty related to chromosomal risk and noninvasive prenatal testing
inferred← citeshttps://doi.org/10.1177/14777509261433775openalex-snapshot
Empowering women's choice in the new era of non-invasive prenatal testing methods: Opting for routine perinatal care information over routine screening
inferred← citeshttps://doi.org/10.1177/17446295251343689openalex-snapshot
Parents of individuals with Down’s syndrome: Opinions and experience of prenatal testing
inferred← citeshttps://doi.org/10.1186/s12884-021-03570-6openalex-snapshot
Efficiency of non-invasive prenatal screening in pregnant women at advanced maternal age
inferred← citeshttps://doi.org/10.1186/s12884-021-04360-wopenalex-snapshot
The impact of prenatal screening tests on prenatal diagnosis in Taiwan from 2006 to 2019: a regional cohort study
inferred← citeshttps://doi.org/10.1186/s12884-022-05110-2openalex-snapshot
Patient experience with non-invasive prenatal testing (NIPT) as a primary screen for aneuploidy in the Netherlands
inferred← citeshttps://doi.org/10.1186/s12884-024-06774-8openalex-snapshot
Pregnancies with ‘double-positive’ multiple marker screening results: a population-based study in Ontario, Canada
inferred← citeshttps://doi.org/10.1186/s12889-022-14685-6openalex-snapshot
Investigating informed choice in screening programmes: a mixed methods analysis
inferred← citeshttps://doi.org/10.1186/s12920-025-02086-8openalex-snapshot
Visualization using NIPTviewer support the clinical interpretation of noninvasive prenatal testing results
inferred← citeshttps://doi.org/10.1186/s12982-025-00596-5openalex-snapshot
Prenatal screening educational interventions for U.S. pregnant women: a scoping review
inferred← citeshttps://doi.org/10.1186/s13039-021-00550-5openalex-snapshot
Clinical application of noninvasive prenatal testing in the detection of fetal chromosomal diseases
inferred← citeshttps://doi.org/10.1186/s13039-024-00702-3openalex-snapshot
Performance of cell free DNA as a screening tool based on the results of first trimester screening
inferred← citeshttps://doi.org/10.1192/j.eurpsy.2022.2355openalex-snapshot
Triple X syndrome: Psychiatric disorders and impaired social functioning as a risk factor
inferred← citeshttps://doi.org/10.1200/op.23.00594openalex-snapshot
Comprehensive Recommendations for the Clinical Management of Pregnant Women With Noninvasive Prenatal Test Results Suspicious of a Maternal Malignancy
inferred← citeshttps://doi.org/10.1371/journal.pmed.1004790openalex-snapshot
Clinical and economic impact of genome-wide non-invasive prenatal testing (NIPT) as a first-tier screening method compared to targeted NIPT and first-trimester combined testing: A modeling study
inferred← citeshttps://doi.org/10.1371/journal.pone.0267865openalex-snapshot
Nationwide implementation of the non-invasive prenatal test: Evaluation of a blended learning program for counselors
inferred← citeshttps://doi.org/10.1371/journal.pone.0277010openalex-snapshot
Health professionals and scientists’ views on genome-wide NIPT in the French public health system: Critical analysis of the ethical issues raised by prenatal genomics
inferred← citeshttps://doi.org/10.1371/journal.pone.0291622openalex-snapshot
Economic evaluation of prenatal screening for fetal aneuploidies in Thailand
inferred← citeshttps://doi.org/10.1371/journal.pone.0298643openalex-snapshot
The implementation and impact of non-invasive prenatal testing (NIPT) for Down’s syndrome into antenatal screening programmes: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.14361/9783839459881openalex-snapshot
Genetic Responsibility in Germany and Israel
inferred← citeshttps://doi.org/10.14361/9783839459881-013openalex-snapshot
8. What Does Prenatal Testing Mean for Women Who Have Tested?
inferred← citeshttps://doi.org/10.1507/endocrj.ej24-0015openalex-snapshot
A case of 49,XXXYY followed-up from infancy to adulthood with review of literature
inferred← citeshttps://doi.org/10.1515/9783839459881openalex-snapshot
Genetic Responsibility in Germany and Israel
inferred← citeshttps://doi.org/10.1515/9783839459881-013openalex-snapshot
8. What Does Prenatal Testing Mean for Women Who Have Tested?
inferred← citeshttps://doi.org/10.1515/jpem-2024-0523openalex-snapshot
Infant gonadotropins predict spontaneous puberty in girls with Turner syndrome
inferred← citeshttps://doi.org/10.1515/jpm-2021-0467openalex-snapshot
Cost of providing cell-free DNA screening for Down syndrome in Finland using different strategies
inferred← citeshttps://doi.org/10.1515/labmed-2022-0023openalex-snapshot
Non-invasive prenatal screening tests – update 2022
inferred← citeshttps://doi.org/10.1530/ec-22-0494openalex-snapshot
Neurocognitive and behavioral development in young children (1–7 years) with sex chromosome trisomy
inferred← citeshttps://doi.org/10.1537/ase.2210241openalex-snapshot
Genetic technologies and the interplay between public desire, commercial interests, and regulatory powers
inferred← citeshttps://doi.org/10.15690/vramn2006openalex-snapshot
Non-Invasive Prenatal Testing: the International Experience of Medical and Economic NIPT Efficiency Evaluation
inferred← citeshttps://doi.org/10.17827/aktd.1013719openalex-snapshot
İnvaziv Olmayan Prenatal Teste Etik Bakış
inferred← citeshttps://doi.org/10.18370/2309-4117.2021.60.21-30openalex-snapshot
Performance capabilities of prenatal diagnosis of chromosomal anomalies: what changed with the introduction of non-invasive prenatal test (NIPT)?
inferred← citeshttps://doi.org/10.20517/evcna.2022.23openalex-snapshot
Towards responsible ctDNA-based multi-cancer screening: a preliminary exploration and discussion of ethically relevant aspects
inferred← citeshttps://doi.org/10.20944/preprints202506.2158.v1openalex-snapshot
A Comprehensive Review of Artificial Intelligence-Driven Enhancements in Non-Invasive Prenatal Testing: Advancing Genomic Precision Through Deep Learning and Computational Genomics
inferred← citeshttps://doi.org/10.21203/rs.3.rs-297925/v1openalex-snapshot
The Clinical Application of Non-invasive Prenatal Genetic Testing in the Screening of Fetal Chromosomal Diseases
inferred← citeshttps://doi.org/10.2147/ijn.s479297openalex-snapshot
Non-Invasive Prenatal Diagnosis of Chromosomal and Monogenic Disease by a Novel Bioinspired Micro–Nanochip for Isolating Fetal Nucleated Red Blood Cells
inferred← citeshttps://doi.org/10.2147/tacg.s535206openalex-snapshot
Non-Invasive Prenatal Testing in the Kingdom of Saudi Arabia: Current Status of Adoption and Roadmap for the Future
inferred← citeshttps://doi.org/10.21860/medflum2022_280997openalex-snapshot
Metode molekularne dijagnostike u prenatalnoj medicini
inferred← citeshttps://doi.org/10.21926/obm.genet.2103openalex-snapshot
inferred← citeshttps://doi.org/10.21926/obm.genet.2103136openalex-snapshot
Prenatal Testing – What Is It Good For? A Review and Critique
inferred← citeshttps://doi.org/10.26800/lv-145-1-2-7openalex-snapshot
Current view of the application of non-invasive prenatal testing of cell-free circulating fetal DNA from maternal blood
inferred← citeshttps://doi.org/10.29328/journal.japch.1001041openalex-snapshot
Needs in siblings of individuals with Down Syndrome and levels of coping Cali, Colombia
inferred← citeshttps://doi.org/10.3166/rmp-2020-0085openalex-snapshot
Nouvelles techniques génétiques de dépistage et diagnostic anténatals : quels enjeux ?
inferred← citeshttps://doi.org/10.3167/9781571818836openalex-snapshot
CHILDREN AND YOUTH ON THE FRONT LINE
inferred← citeshttps://doi.org/10.33612/diss.245084236openalex-snapshot
Genetics meets ultrasound
inferred← citeshttps://doi.org/10.3389/fgene.2021.741752openalex-snapshot
Screening for Fetal Aneuploidy and Sex Chromosomal Anomalies in a Pregnant Woman With Mosaicism for Turner Syndrome—Applications and Advantages of Cell-Based NIPT
inferred← citeshttps://doi.org/10.3389/fgene.2022.982508openalex-snapshot
Case Report: Two cases of apparent discordance between non-invasive prenatal testing (NIPT) and amniocentesis resulting in feto-placental mosaicism of trisomy 21. Issues in diagnosis, investigation and counselling
inferred← citeshttps://doi.org/10.3389/fgene.2025.1495604openalex-snapshot
Calculating maternal polygenic risk scores from prenatal screening by cell-free DNA data
inferred← citeshttps://doi.org/10.3389/fmed.2021.768997openalex-snapshot
Trends in Non-invasive Prenatal Screening and Invasive Testing in Denmark (2000–2019) and Israel (2011–2019)
inferred← citeshttps://doi.org/10.3389/fmed.2025.1522680openalex-snapshot
The evolution of cell-free fetal DNA testing: expanded non-invasive prenatal testing and its effect on target populations
inferred← citeshttps://doi.org/10.3390/app13074385openalex-snapshot
Adapting the GACT-X Aligner to Accelerate Minimap2 in an FPGA Cloud Instance
inferred← citeshttps://doi.org/10.3390/biomedicines11123284openalex-snapshot
Unraveling Down Syndrome: From Genetic Anomaly to Artificial Intelligence-Enhanced Diagnosis
inferred← citeshttps://doi.org/10.3390/cimb48050534openalex-snapshot
Alpha-Fetoprotein as a Biomarker in Pregnancy: From Genetic Disorders to Obstetric Complications
inferred← citeshttps://doi.org/10.3390/diagnostics12112816openalex-snapshot
Non-Invasive Prenatal Testing in Germany
inferred← citeshttps://doi.org/10.3390/diagnostics13152570openalex-snapshot
Non-Invasive Prenatal Testing (NIPT): Reliability, Challenges, and Future Directions
inferred← citeshttps://doi.org/10.3390/diagnostics14111198openalex-snapshot
Maternal Reassurance, Satisfaction, and Anxiety after First-Trimester Screening for Aneuploidies: Comparison between Contingent Screening and Universal Cell-Free DNA Testing
inferred← citeshttps://doi.org/10.3390/genes12020204openalex-snapshot
Ethical, Legal and Social Issues (ELSI) Associated with Non-Invasive Prenatal Testing: Reflections on the Evolution of Prenatal Diagnosis and Procreative Choices
showing the first 200 of 226 · page through all 226
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.